[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-regeneron-stock-forecast-where-analysts-see-the-stock-going-by-2027-ZH":150},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[],{"post":151,"seo":187,"relatedPosts":193,"suggestedPosts":271},{"id":152,"title":153,"date":154,"modified":155,"excerpt":156,"content":157,"wordCount":158,"lang":159,"uri":160,"slug":161,"cloudinaryAssetId":162,"featuredImageOriginalUrl":163,"featuredImageMetadata":164,"author":167,"editor":173,"categories":178,"relatedPosts":184,"seo":185},83876,"Regeneron 股票预测：分析师眼中的 2027 年股票走向","2025-10-26T14:35:00","2025-10-25T21:58:34","\u003Cp>分析师认为，在强劲的利润率、不断增长的产品线和稳定的创新的推动下，Regeneron 公司（纳斯达克股票代码：REGN）在未来两年的收益率将达到 27%。\u003C\u002Fp>\n","\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=33715&amp;tid=2642551&amp;ref=srk6m3\">\u003Cstrong>再生元制药公司（纳斯达克股票代码：REGN）\u003C\u002Fstrong>\u003C\u002Fa>在过去的一年里举步维艰，股价从 2024 年的峰值下跌了近 38%。股价下跌反映了收入增长疲软，以及旗舰眼药 Eylea 的需求减弱。尽管如此，分析师预计，随着新疗法获得牵引力，盈利能力保持强劲，其股价仍将温和上扬。\u003C\u002Fp>\n\n\n\n\u003Cp>最近，Regeneron 公布了支持 Dupixent 在慢性阻塞性肺病（COPD）中潜在应用的新数据，此前，该公司于 2024 年公布了积极的三期研究结果，目前正在审查 2025 年的监管申请。该公司还报告了其肿瘤学和免疫学管线的持续进展，包括 linvoseltamab 治疗多发性骨髓瘤的扩大试验和评估 Odronextamab 治疗淋巴瘤的新研究。在取得这些研发里程碑的同时，Regeneron 继续产生强劲的现金流，并保持无负债的资产负债表，凸显了其即使在放缓的市场环境中也有能力为长期发展进行投资。\u003C\u002Fp>\n\n\n\n\u003Cp>本文探讨了华尔街分析师对 Regeneron 2027 年交易前景的看法。我们收集了共识目标价和估值模型，勾勒出该股的潜在走势。这些数据反映了当前分析师的预期，并非 TIKR 自己的预测。\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog-compoundersreport\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog-aicompoundersreport\" target=\"_blank\" rel=\"noreferrer noopener\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">使用 TIKR 的新估值模型（免费），在 60 秒内了解股票的真实价值 &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-analyst-price-targets-suggest-modest-upside\">\u003Cstrong>\u003Cstrong>\u003Cstrong>分析师目标股价显示了适度的上涨空间\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Regeneron 的交易价格接近 578 美元\u002F股，而分析师的平均目标价格约为 725 美元\u002F股，这意味着未来一年的上涨空间约为 26%。预测范围相当小，表明分析师持谨慎乐观态度：\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>最高预期：\u003C\u002Fstrong>约 900 美元\u002F股\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>低估值：\u003C\u002Fstrong>~543 美元\u002F股\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>目标中值：\u003C\u002Fstrong>~750 美元\u002F股\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>评级：\u003C\u002Fstrong>15家买入，4家跑赢大盘，6家持有，1家跑输大盘\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>看来，分析师们仍然认为公司还有上涨空间，但预期是平衡的。对于投资者来说，Regeneron 被视为一个稳定的复合型企业，而不是一个突破性企业。其强大的产品线和现金状况为其适度上扬提供了支持，如果执行情况保持良好的话。\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1111\" height=\"699\" data-public-id=\"images\u002FREGENERON-2\u002FREGENERON-2.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1111,h_699,c_scale\u002Ff_webp,q_auto\u002Fv1761429084\u002Fimages\u002FREGENERON-2\u002FREGENERON-2.webp?_i=AA\" alt=\"Regeneron Pharmaceuticals stock\" class=\"wp-post-83876 wp-image-83878\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1761429084\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1761429084\u002Fimages\u002FREGENERON-2\u002FREGENERON-2.webp?_i=AA 1111w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_189,c_scale\u002Ff_webp,q_auto\u002Fv1761429084\u002Fimages\u002FREGENERON-2\u002FREGENERON-2.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_644,c_scale\u002Ff_webp,q_auto\u002Fv1761429084\u002Fimages\u002FREGENERON-2\u002FREGENERON-2.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_483,c_scale\u002Ff_webp,q_auto\u002Fv1761429084\u002Fimages\u002FREGENERON-2\u002FREGENERON-2.webp?_i=AA 768w\" sizes=\"auto, (max-width: 1111px) 100vw, 1111px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Regeneron Pharmaceuticals 分析师目标价\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">使用 TIKR 的新估值模型（免费）了解您最喜爱的股票的上涨空间 &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-regeneron-growth-outlook-and-valuation\">再生元：增长前景和估值\u003C\u002Fh2>\n\n\n\n\u003Cp>Regeneron 的基本面依然稳健，但与高峰时期相比，增长速度有所放缓：\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>预计到 2027 年，收入年增长率约为 4\u003C\u002Fli>\n\n\n\n\u003Cli>营业利润率应保持在 34% 附近\u003C\u002Fli>\n\n\n\n\u003Cli>股价约为远期收益的 15 倍，略低于 5 年平均水平\u003C\u002Fli>\n\n\n\n\u003Cli>根据分析师的平均估计，TIKR 的指导估值模型采用 14.7 倍的远期市盈率，表明到 2027 年每股收益约为 734 美元。\u003C\u002Fli>\n\n\n\n\u003Cli>这意味着总上升空间约为 27%，年回报率约为 12\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>这些数据表明，在稳定的盈利和规范的资本配置支持下，Regeneron 可以继续保持稳定的复合增长。对于投资者来说，该股的价格与其增长状况相当，如果利润率保持强劲，新疗法势头良好，该股就能带来稳健的回报。\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1934\" height=\"2560\" data-public-id=\"images\u002FREGN_valuation_model_838793199a\u002FREGN_valuation_model_838793199a.webp\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1934,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1761429107\u002Fimages\u002FREGN_valuation_model_838793199a\u002FREGN_valuation_model_838793199a.webp?_i=AA\" alt=\"Regeneron Pharmaceuticals stock\" class=\"wp-post-83876 wp-image-83879\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1761429107\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">再生元制药公司指导估值模型结果\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">在 60 秒内查看股票的真实价值（使用 TIKR 免费） &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-s-driving-the-optimism\">是什么推动了乐观情绪？\u003C\u002Fh2>\n\n\n\n\u003Cp>Regeneron 的创新管道仍然是生物技术领域最有前途的管道之一。公司的抗体平台不断开发出肿瘤、免疫和罕见病领域的新疗法。Dupixent 仍是公司的增长引擎，包括慢性阻塞性肺病在内的适应症不断扩大，有可能推动下一阶段的收入增长。\u003C\u002Fp>\n\n\n\n\u003Cp>公司对研发效率的关注和强劲的现金流也为持续的创新再投资提供了支持。对投资者来说，这些优势表明，Regeneron 可以在逐步重建业绩增长势头的同时保持盈利能力。它在科学领域的领先记录让人相信，它能抵御短期的不利因素。\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-bear-case-slower-growth-and-pipeline-risk\">\u003Cstrong>\u003Cstrong>\u003Cstrong>熊市案例：增长放缓和管线风险\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>尽管有这些利好因素，Regeneron 的近期增长仍然有限。Eylea 仍占销售额的很大一部分，而且面临着生物仿制药和视网膜市场新进入者日益激烈的竞争。如果新药的规模化需要更长的时间，盈利可能会停滞不前。\u003C\u002Fp>\n\n\n\n\u003Cp>估值还假设了稳定的利润率和稳定的产品上市。产品线的任何延误或定价压力都会影响回报。对投资者来说，风险在于即使基本面强劲，Regeneron 的增长速度也会放缓，从而导致股价横盘。\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-outlook-for-2027-what-could-regeneron-be-worth\">2027 年展望：Regeneron 值多少钱？\u003C\u002Fh2>\n\n\n\n\u003Cp>根据分析师的平均估计，TIKR 的指导估值模型采用 14.7 倍的远期市盈率，认为到 2027 年，Regeneron 的交易价格可能接近每股 734 美元。这意味着总的上升空间约为 27%，或与当前水平相比的年回报率约为 12%。\u003C\u002Fp>\n\n\n\n\u003Cp>虽然这意味着适度的上升空间，但已经考虑到了稳定的利润率和持续成功的产品线。要实现更高的回报率，Regeneron 需要在 Dupixent 等关键项目及其新兴的肿瘤项目组合上取得超出预期的成绩。\u003C\u002Fp>\n\n\n\n\u003Cp>对投资者来说，Regeneron 兼顾了创新、盈利能力和财务实力。它可能不再是一个高增长的名字，但它仍然是一家能够带来长期稳定收益的优质生物技术合成公司。\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">了解您喜爱的股票的真实价值（使用 TIKR 免费） &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-ai-compounders-with-massive-upside-that-wall-street-is-overlooking\">\u003Cstrong>华尔街忽视的具有巨大上升空间的人工智能复合企业\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>人人都想从人工智能中套现。但是，当人们追逐英伟达（NVIDIA）、AMD 或台湾半导体（Taiwan Semiconductor）等明显受益于人工智能的公司时，真正的机会可能在\u003Cem>人工智能应用层\u003C\u002Fem>，在那里，一些复合型公司正在悄悄地将人工智能嵌入人们日常使用的产品中。\u003C\u002Fp>\n\n\n\n\u003Cp>TIKR 刚刚发布了一份新的免费报告，介绍了 5 家价值被低估的化合物公司，分析师认为，随着人工智能应用的加速，这些公司可能会在数年内实现超额收益。\u003C\u002Fp>\n\n\n\n\u003Cp>在这份报告中，您将发现\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>已将人工智能转化为收入和盈利增长的企业\u003C\u002Fstrong>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>尽管分析师预测强劲，但交易价格低于公允价值的股票\u003C\u002Fstrong>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>大多数投资者尚未考虑过的独特选择\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>如果您想抓住下一波人工智能风口，本报告是您的必读之选。\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog-compoundersreport\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog-aicompoundersreport\" target=\"_blank\" rel=\"noreferrer noopener\">单击此处注册 TIKR，立即免费获取 TIKR 的 5 AI 复合型企业报告。\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n",908,"zh","\u002Fblog\u002Fregeneron-stock-forecast-where-analysts-see-the-stock-going-by-2027","regeneron-stock-forecast-where-analysts-see-the-stock-going-by-2027","images\u002FRegeneron-Pharmaceuticals-stock\u002FRegeneron-Pharmaceuticals-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761428998\u002Fimages\u002FRegeneron-Pharmaceuticals-stock\u002FRegeneron-Pharmaceuticals-stock.png?_i=AA",{"altText":165,"imageCredit":166},"Regeneron Stock Forecast: Where Analysts See the Stock Going by 2027","@MJPS from Getty Images via Canva",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":172},"Nikko Henson","nikkotikr","author","",[],{"name":174,"slug":175,"role":176,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":177},"Thomas Richmond","thomastikr","editor",[],[179],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},"股票评论","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":165,"metaDesc":186,"opengraphDescription":186,"twitterTitle":165,"twitterDescription":186},"Here’s why analysts believe Regeneron (NASDAQ: REGN) could gain about 27% over the next two years, driven by strong margins, a growing pipeline, and steady innovation.",{"title":165,"description":186,"twitterTitle":165,"twitterDescription":186,"author":168,"articlePublisher":188,"articlePublishedTime":154,"articleModifiedTime":155,"twitterLabel1":189,"twitterData1":190,"ogTitle":165,"ogDescription":186,"ogUrl":160,"ogImage":163,"ogImageWidth":191,"ogImageHeight":192,"ogImageSecureUrl":163,"ogImageAlt":165,"twitterImage":163},"TIKR.com","预计阅读时间","2 minutes",1200,630,[194,211,226,241,256],{"id":183,"title":195,"date":196,"excerpt":197,"wordCount":198,"uri":199,"slug":200,"cloudinaryAssetId":201,"featuredImageOriginalUrl":202,"featuredImageMetadata":203,"author":204,"categories":208,"relatedPosts":210},"Dollarama 2025 年的扩张证明了价值零售正在走向全球","2025-10-26 14:28:00","Dollarama 最近一个季度不仅带来了丰厚的收益，还标志着该公司正在向全球价值零售业巨头转型。\n",1463,"\u002Fblog\u002Fdollaramas-2025-expansion-proves-that-value-retail-is-going-global","dollaramas-2025-expansion-proves-that-value-retail-is-going-global","images\u002FDollarama-Featured\u002FDollarama-Featured","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761336870\u002Fimages\u002FDollarama-Featured\u002FDollarama-Featured.png?_i=AA",{"altText":195},{"name":205,"slug":206,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":207},"David Beren","davidberentikr",[],[209],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":212,"date":213,"excerpt":214,"wordCount":215,"uri":216,"slug":217,"cloudinaryAssetId":218,"featuredImageOriginalUrl":219,"featuredImageMetadata":220,"author":221,"categories":223,"relatedPosts":225},"Vertex Pharmaceuticals 股票预测：分析师眼中的 2027 年股票走向","2025-10-26 14:05:00","以下是分析师认为 Vertex 制药公司（纳斯达克股票代码：VRTX）股价到 2027 年可能上涨约 22% 的原因：强劲的利润率、稳定的增长以及基因编辑和疼痛治疗领域的新突破。",957,"\u002Fblog\u002Fvertex-pharmaceuticals-stock-forecast-where-analysts-see-the-stock-going-by-2027","vertex-pharmaceuticals-stock-forecast-where-analysts-see-the-stock-going-by-2027","images\u002FVertex-Pharmaceuticals-stock\u002FVertex-Pharmaceuticals-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761427162\u002Fimages\u002FVertex-Pharmaceuticals-stock\u002FVertex-Pharmaceuticals-stock.png?_i=AA",{"altText":212},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":222},[],[224],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":227,"date":228,"excerpt":229,"wordCount":230,"uri":231,"slug":232,"cloudinaryAssetId":233,"featuredImageOriginalUrl":234,"featuredImageMetadata":235,"author":236,"categories":238,"relatedPosts":240},"百健股票预测：分析师眼中的 2027 年股价走势","2025-10-26 13:35:00","分析师认为，在稳定的利润率、稳健的现金流和阿尔茨海默氏症专营权稳定增长的支持下，百健公司（纳斯达克股票代码：BIIB）的股价在未来两年将有约 1.8% 的上涨空间。",890,"\u002Fblog\u002Fbiogen-stock-forecast-where-analysts-see-the-stock-going-by-2027","biogen-stock-forecast-where-analysts-see-the-stock-going-by-2027","images\u002FBiogen-stock\u002FBiogen-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761425025\u002Fimages\u002FBiogen-stock\u002FBiogen-stock.png?_i=AA",{"altText":227},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":237},[],[239],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":242,"date":243,"excerpt":244,"wordCount":245,"uri":246,"slug":247,"cloudinaryAssetId":248,"featuredImageOriginalUrl":249,"featuredImageMetadata":250,"author":251,"categories":253,"relatedPosts":255},"Shopify在2025年的反弹是否过头了？","2025-10-26 13:08:00","Shopify 的增长引擎再次全速运转。但随着该公司股价在过去一年中上涨了近 90%，投资者不禁要问：反弹是否过头了？\n",1272,"\u002Fblog\u002Fhas-shopifys-2025-rally-gone-too-far-or-is-there-more-room-to-run","has-shopifys-2025-rally-gone-too-far-or-is-there-more-room-to-run","images\u002FShopify-Featured\u002FShopify-Featured","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761332658\u002Fimages\u002FShopify-Featured\u002FShopify-Featured.png?_i=AA",{"altText":242},{"name":205,"slug":206,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":252},[],[254],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":257,"date":258,"excerpt":259,"wordCount":260,"uri":261,"slug":262,"cloudinaryAssetId":263,"featuredImageOriginalUrl":264,"featuredImageMetadata":265,"author":266,"categories":268,"relatedPosts":270},"吉利德科学公司股票预测：分析师眼中的 2027 年股票走向","2025-10-26 13:05:00","以下是分析师认为吉利德科学公司（纳斯达克股票代码：GILD）到 2027 年可能会有约 3% 的上涨空间的原因，其驱动力是稳定的艾滋病增长、新药上市和可靠的股息收入。",818,"\u002Fblog\u002Fgilead-sciences-stock-forecast-where-analysts-see-the-stock-going-by-2027","gilead-sciences-stock-forecast-where-analysts-see-the-stock-going-by-2027","images\u002FGilead-Sciences-stock\u002FGilead-Sciences-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761423716\u002Fimages\u002FGilead-Sciences-stock\u002FGilead-Sciences-stock.png?_i=AA",{"altText":257},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":267},[],[269],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],[272,292,309,324,339,354,372,387,402,417,432,450,465,481],{"id":183,"title":273,"date":274,"excerpt":275,"wordCount":276,"uri":277,"slug":278,"cloudinaryAssetId":279,"featuredImageOriginalUrl":280,"featuredImageMetadata":281,"author":282,"categories":286,"relatedPosts":291},"诺华股票预测：诺华的发展动力及其下一步走向","2025-10-25 15:25:00","诺华公司（NYSE: NVS）凭借强劲的盈利、重点突出的产品线以及 Cosentyx 和 Entresto 等关键药物的稳定增长，赢得了投资者的青睐。以下是推动该公司股票上涨的因素，以及下一步可能的走势。",679,"\u002Fblog\u002Fnovartis-stock-forecast-whats-driving-novn-and-where-it-could-go-next","novartis-stock-forecast-whats-driving-novn-and-where-it-could-go-next","images\u002FNovartis-Stock\u002FNovartis-Stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761122412\u002Fimages\u002FNovartis-Stock\u002FNovartis-Stock.png?_i=AA",{"altText":273},{"name":283,"slug":284,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":285},"Roxanna Maglangit","roxtikr",[],[287],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},"估价","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":183,"title":293,"date":294,"excerpt":295,"wordCount":296,"uri":297,"slug":298,"cloudinaryAssetId":299,"featuredImageOriginalUrl":300,"featuredImageMetadata":301,"author":302,"categories":306,"relatedPosts":308},"过去十年涨幅高达 350%，CNQ 股票现在还值得买吗？","2025-10-24 16:00:00","加拿大自然资源公司股票在过去十年中为股东带来了超过 300% 的回报。CNQ 股票是否仍然值得购买？",1254,"\u002Fblog\u002Fup-350-in-the-past-decade-is-cnq-stock-still-a-good-buy-right-now","up-350-in-the-past-decade-is-cnq-stock-still-a-good-buy-right-now","images\u002FNEW-FEATURED-IMAGE-MAKER-18-18\u002FNEW-FEATURED-IMAGE-MAKER-18-18","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761305366\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-18\u002FNEW-FEATURED-IMAGE-MAKER-18-18.png?_i=AA",{"altText":293},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":305},"Aditya Raghunath","adityatikr",[],[307],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},[],{"id":183,"title":310,"date":311,"excerpt":312,"wordCount":313,"uri":314,"slug":315,"cloudinaryAssetId":316,"featuredImageOriginalUrl":317,"featuredImageMetadata":318,"author":319,"categories":321,"relatedPosts":323},"安联股价预测：2025 年 10 月，这家保险业巨头的价值是否被低估？","2025-10-24 14:00:00","在过去十年中，安联股票给投资者带来的回报翻了一番多。这家保险巨头是否仍然值得购买？",1188,"\u002Fblog\u002Fallianz-stock-price-prediction-is-the-insurance-giant-undervalued-in-october-2025","allianz-stock-price-prediction-is-the-insurance-giant-undervalued-in-october-2025","images\u002FNEW-FEATURED-IMAGE-MAKER-18-17\u002FNEW-FEATURED-IMAGE-MAKER-18-17","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761303777\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-17\u002FNEW-FEATURED-IMAGE-MAKER-18-17.png?_i=AA",{"altText":310},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":320},[],[322],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},[],{"id":183,"title":325,"date":326,"excerpt":327,"wordCount":328,"uri":329,"slug":330,"cloudinaryAssetId":331,"featuredImageOriginalUrl":332,"featuredImageMetadata":333,"author":334,"categories":336,"relatedPosts":338},"过去三年上涨 1,400% 的劳斯莱斯股票是否仍然值得购买？","2025-10-23 16:00:00","自 2022 年底以来，罗尔斯-罗伊斯公司股票一路狂飙，涨幅高达 1400%。这家制造业巨头是否仍然值得买入？",1226,"\u002Fblog\u002Fup-1400-in-the-last-3-years-is-rolls-royce-stock-still-a-good-buy","up-1400-in-the-last-3-years-is-rolls-royce-stock-still-a-good-buy","images\u002FNEW-FEATURED-IMAGE-MAKER-18-12\u002FNEW-FEATURED-IMAGE-MAKER-18-12","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761228434\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-12\u002FNEW-FEATURED-IMAGE-MAKER-18-12.png?_i=AA",{"altText":325},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":335},[],[337],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},[],{"id":183,"title":340,"date":341,"excerpt":342,"wordCount":343,"uri":344,"slug":345,"cloudinaryAssetId":346,"featuredImageOriginalUrl":347,"featuredImageMetadata":348,"author":349,"categories":351,"relatedPosts":353},"阿斯利康股价预测：这家医疗保健巨头的价值是否被低估？","2025-10-23 15:00:00","鉴于阿斯利康的预期增长率和强大的产品组合，2025 年 10 月阿斯利康股票的估值令人信服。 ",1182,"\u002Fblog\u002Fastrazeneca-stock-price-prediction-is-this-healthcare-giant-undervalued","astrazeneca-stock-price-prediction-is-this-healthcare-giant-undervalued","images\u002FNEW-FEATURED-IMAGE-MAKER-18-11\u002FNEW-FEATURED-IMAGE-MAKER-18-11","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761225919\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-11\u002FNEW-FEATURED-IMAGE-MAKER-18-11.png?_i=AA",{"altText":340},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":350},[],[352],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},[],{"id":183,"title":355,"date":356,"excerpt":357,"wordCount":358,"uri":359,"slug":360,"cloudinaryAssetId":361,"featuredImageOriginalUrl":362,"featuredImageMetadata":363,"author":364,"categories":366,"relatedPosts":371},"卡彭特科技公司股票昨天为何上涨超过 22%？","2025-10-24 13:30:00","卡彭特科技公司第一财季的业绩超过了一致预期，股价在一个交易日内飙升了 22% 以上。 ",768,"\u002Fblog\u002Fwhy-did-carpenter-technology-nyse-crs-stock-rise-over-22-yesterday","why-did-carpenter-technology-nyse-crs-stock-rise-over-22-yesterday","images\u002FNEW-FEATURED-IMAGE-MAKER-18-16\u002FNEW-FEATURED-IMAGE-MAKER-18-16","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761298285\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-16\u002FNEW-FEATURED-IMAGE-MAKER-18-16.png?_i=AA",{"altText":355},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":365},[],[367],{"name":368,"slug":369,"uri":370,"description":171,"postsCount":183},"收益更新","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[],{"id":183,"title":373,"date":374,"excerpt":375,"wordCount":376,"uri":377,"slug":378,"cloudinaryAssetId":379,"featuredImageOriginalUrl":380,"featuredImageMetadata":381,"author":382,"categories":384,"relatedPosts":386},"尽管下调了 2025 年的指导目标，福特股价仍上涨近 3","2025-10-24 12:30:00","福特汽车股价上涨近 3%，因为这家汽车巨头 2025 年第三季度的营收和盈利均超出预期。 ",1074,"\u002Fblog\u002Fford-stock-rises-almost-3-despite-lower-guidance-for-2025","ford-stock-rises-almost-3-despite-lower-guidance-for-2025","images\u002FNEW-FEATURED-IMAGE-MAKER-18-14\u002FNEW-FEATURED-IMAGE-MAKER-18-14","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761292467\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-14\u002FNEW-FEATURED-IMAGE-MAKER-18-14.png?_i=AA",{"altText":373},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":383},[],[385],{"name":368,"slug":369,"uri":370,"description":171,"postsCount":183},[],{"id":183,"title":388,"date":389,"excerpt":390,"wordCount":391,"uri":392,"slug":393,"cloudinaryAssetId":394,"featuredImageOriginalUrl":395,"featuredImageMetadata":396,"author":397,"categories":399,"relatedPosts":401},"英特尔第三季度营收超出一致预期，股价大涨 7","2025-10-24 12:00:00","英特尔公司 2025 年第三季度营收和盈利均超出预期，股价上涨超过 7%。 ",1019,"\u002Fblog\u002Fintel-stock-surges-7-as-q3-revenue-beats-consensus-estimates","intel-stock-surges-7-as-q3-revenue-beats-consensus-estimates","images\u002FNEW-FEATURED-IMAGE-MAKER-18-13_83766f85dd\u002FNEW-FEATURED-IMAGE-MAKER-18-13_83766f85dd","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761290823\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-13_83766f85dd\u002FNEW-FEATURED-IMAGE-MAKER-18-13_83766f85dd.png?_i=AA",{"altText":388},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":398},[],[400],{"name":368,"slug":369,"uri":370,"description":171,"postsCount":183},[],{"id":183,"title":403,"date":404,"excerpt":405,"wordCount":406,"uri":407,"slug":408,"cloudinaryAssetId":409,"featuredImageOriginalUrl":410,"featuredImageMetadata":411,"author":412,"categories":414,"relatedPosts":416},"西南航空第四季度收入创历史新高，股价上涨 1","2025-10-23 14:30:00","西南航空公司（Southwest Airlines）预计 2025 年第四季度销售额将创历史新高，该公司股票在早盘交易中上涨。 ",1089,"\u002Fblog\u002Fsouthwest-luv-stock-gains-1-as-airline-beats-q3-estimates","southwest-luv-stock-gains-1-as-airline-beats-q3-estimates","images\u002FNEW-FEATURED-IMAGE-MAKER-18-10_8368417a1d\u002FNEW-FEATURED-IMAGE-MAKER-18-10_8368417a1d","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761219147\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-10_8368417a1d\u002FNEW-FEATURED-IMAGE-MAKER-18-10_8368417a1d.png?_i=AA",{"altText":403},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":413},[],[415],{"name":368,"slug":369,"uri":370,"description":171,"postsCount":183},[],{"id":183,"title":418,"date":419,"excerpt":420,"wordCount":421,"uri":422,"slug":423,"cloudinaryAssetId":424,"featuredImageOriginalUrl":425,"featuredImageMetadata":426,"author":427,"categories":429,"relatedPosts":431},"德州仪器股价下跌近 6%，原因是管理层对前景持谨慎态度","2025-10-23 12:30:00","德州仪器（Texas Instruments）的股价下跌了 5%以上，因为这家芯片制造商提供的谨慎指导未能达到预期。 ",1001,"\u002Fblog\u002Ftexas-instruments-nasdaq-txn-stock-falls-cautious-management-outlook","texas-instruments-nasdaq-txn-stock-falls-cautious-management-outlook","images\u002FNEW-FEATURED-IMAGE-MAKER-18-7\u002FNEW-FEATURED-IMAGE-MAKER-18-7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761214918\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-7\u002FNEW-FEATURED-IMAGE-MAKER-18-7.png?_i=AA",{"altText":418},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":428},[],[430],{"name":368,"slug":369,"uri":370,"description":171,"postsCount":183},[],{"id":183,"title":433,"date":434,"excerpt":435,"wordCount":436,"uri":437,"slug":438,"cloudinaryAssetId":439,"featuredImageOriginalUrl":440,"featuredImageMetadata":441,"author":442,"categories":444,"relatedPosts":449},"超级微型计算机初步业绩疲软，股价下跌近 9","2025-10-24 13:00:00","2025 年 10 月，SMCI 股票从历史高点下跌近 60%，继续令投资者失望。 ",1031,"\u002Fblog\u002Fsuper-micro-computer-stock-sinks-almost-9-on-weak-preliminary-results","super-micro-computer-stock-sinks-almost-9-on-weak-preliminary-results","images\u002FNEW-FEATURED-IMAGE-MAKER-18-15\u002FNEW-FEATURED-IMAGE-MAKER-18-15","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761295689\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-15\u002FNEW-FEATURED-IMAGE-MAKER-18-15.png?_i=AA",{"altText":433},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":443},[],[445],{"name":446,"slug":447,"uri":448,"description":171,"postsCount":183},"一般投资","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":183,"title":451,"date":452,"excerpt":453,"wordCount":454,"uri":455,"slug":456,"cloudinaryAssetId":457,"featuredImageOriginalUrl":458,"featuredImageMetadata":459,"author":460,"categories":462,"relatedPosts":464},"Beyond Meat 股票大涨 600%，因为 Meme 交易商跃跃欲试","2025-10-22 14:00:00","Beyond Meat 是一只 \"备忘录 \"股票，由于散户投资者发起的空头挤压，它在过去三个交易日中上涨了 600%。 ",871,"\u002Fblog\u002Fbeyond-meat-stock-surges-600-as-meme-traders-jump-on-board","beyond-meat-stock-surges-600-as-meme-traders-jump-on-board","images\u002FNEW-FEATURED-IMAGE-MAKER-18-3\u002FNEW-FEATURED-IMAGE-MAKER-18-3","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1761139704\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-18-3\u002FNEW-FEATURED-IMAGE-MAKER-18-3.png?_i=AA",{"altText":451},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":461},[],[463],{"name":446,"slug":447,"uri":448,"description":171,"postsCount":183},[],{"id":183,"title":466,"date":467,"excerpt":468,"wordCount":469,"uri":470,"slug":471,"cloudinaryAssetId":472,"featuredImageOriginalUrl":473,"featuredImageMetadata":474,"author":475,"categories":478,"relatedPosts":480},"iPhone 17 需求强劲，苹果股价飙升至历史新高","2025-10-21T13:30:00","\u003Cp>由于投资者对 2025 年 iPhone 的强劲销售持乐观态度，苹果公司股价刚刚创下历史新高。 \u003C\u002Fp>\n",1087,"\u002Fblog\u002Fapple-stock-surges-to-all-time-highs-on-strong-iphone-17-demand","apple-stock-surges-to-all-time-highs-on-strong-iphone-17-demand","images\u002FNEW-FEATURED-IMAGE-MAKER-16-1_829620d0b3\u002FNEW-FEATURED-IMAGE-MAKER-16-1_829620d0b3","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1761045495\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-16-1_829620d0b3\u002FNEW-FEATURED-IMAGE-MAKER-16-1_829620d0b3.?_i=AA",{"altText":466},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":476,"socialMediaLinks":477},"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_auto,q_auto,w_448\u002Fimages\u002Fdb_4795590495\u002Fdb_4795590495",[],[479],{"name":446,"slug":447,"uri":448,"description":171,"postsCount":183},[],{"id":183,"title":482,"date":483,"excerpt":484,"wordCount":485,"uri":486,"slug":487,"cloudinaryAssetId":488,"featuredImageOriginalUrl":489,"featuredImageMetadata":490,"author":491,"categories":493,"relatedPosts":495},"甲骨文股价为何从历史高点下跌 16%？","2025-10-21T13:00:00","\u003Cp>2025 年 10 月，由于投资者对这家云计算巨头的高估值持谨慎态度，甲骨文股价从历史高点下跌了 16%。 \u003C\u002Fp>\n",980,"\u002Fblog\u002Fwhy-is-oracle-nyse-orcl-stock-down-16-from-all-time-highs","why-is-oracle-nyse-orcl-stock-down-16-from-all-time-highs","images\u002FNEW-FEATURED-IMAGE-MAKER-16_829067c4c5\u002FNEW-FEATURED-IMAGE-MAKER-16_829067c4c5","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1761043617\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-16_829067c4c5\u002FNEW-FEATURED-IMAGE-MAKER-16_829067c4c5.?_i=AA",{"altText":482},{"name":303,"slug":304,"role":170,"roleTitle":171,"biography":171,"avatar":476,"socialMediaLinks":492},[],[494],{"name":446,"slug":447,"uri":448,"description":171,"postsCount":183},[]]